{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:12:05Z","timestamp":1790107925816,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012615","name":"University of Texas Health Science Center at Houston","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012615","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.atherosclerosis.2026.120831","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T06:52:40Z","timestamp":1782802360000},"page":"120831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Quantitative PET coronary flow capacity and comprehensive management of chronic CAD: Lessons from the randomized CENTURY trial"],"prefix":"10.1016","volume":"419","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4019-5941","authenticated-orcid":false,"given":"K. Lance","family":"Gould","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils P.","family":"Johson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2026.120831_bib1","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.jacc.2013.01.044","article-title":"Risk factor control for coronary artery disease secondary prevention in large randomized trials","volume":"61","author":"Farkouh","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib2","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib3","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A randomized trial of therapies for type 2 diabetes and coronary artery disease","volume":"360","author":"Bari 2D","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib4","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib5","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0140-6736(15)00057-4","article-title":"Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-Year follow-up of a randomized controlled trial","volume":"386","author":"van Nunen","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib6","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jacc.2019.11.058","article-title":"Stent-related adverse events >1 year after percutaneous coronary intervention","volume":"75","author":"Madhavan","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib7","first-page":"656","article-title":"Are our tools for the identification of TCFA ready and do we know them?","volume":"4","author":"Virmani","year":"2011","journal-title":"J Am Coll Cardiol CV Imag"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib8","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.jacc.2014.01.061","article-title":"Distinct morphological features of ruptured culprit plaque for acute coronary events compared to those with silent rupture and thin-cap fibroatheroma: a combined optical coherence tomography and intravascular ultrasound study","volume":"63","author":"Tian","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/eurheartj\/ehad579","article-title":"Coronary flow capacity and survival prediction after revascularization: physiological basis and clinical implications","volume":"45","author":"Gould","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib10","first-page":"78","article-title":"Subendocardial and transmural myocardial ischemia: clinical characteristics, prevalence, and outcomes with and without revascularization","volume":"16","author":"Gould","year":"2023","journal-title":"J Am Coll Cardiol Cardiovasc Imaging"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib11","first-page":"1020","article-title":"Mortality prediction by quantitative PET perfusion expressed as coronary flow capacity with and without revascularization","volume":"14","author":"Gould","year":"2021","journal-title":"J Am Coll Cardiol Cardiovasc Imaging"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib12","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2967\/jnumed.118.211953","article-title":"Regional, artery-specific thresholds of quantitative myocardial perfusion by PET associated with reduced myocardial infarction and death after revascularization in stable coronary artery disease","volume":"60","author":"Gould","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib13","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1016\/j.jacc.2018.07.106","article-title":"Coronary physiology beyond coronary flow reserve in microvascular angina: State-of-the-Art review","volume":"72","author":"Gould","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib14","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.jacc.2013.07.076","article-title":"Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making","volume":"62","author":"Gould","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib15","first-page":"430","article-title":"Integrating non-invasive absolute flow, coronary flow reserve, and ischemic thresholds into a comprehensive map of physiological severity","volume":"5","author":"Johnson","year":"2012","journal-title":"J Am Coll Cardiol Cardiovasc Imaging"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib16","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/CIRCIMAGING.113.000373","article-title":"Coronary anatomy to predict physiology \u2013 fundamental limits","volume":"6","author":"Johnson","year":"2013","journal-title":"Circ, Cardiovasc Imaging"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0735-1097(02)02693-1","article-title":"Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease","volume":"41","author":"Sdringola","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0002-9149(74)90743-7","article-title":"A physiologic basis for assessing critical coronary stenosis: instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve","volume":"33","author":"Gould","year":"1974","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib19","doi-asserted-by":"crossref","unstructured":"Gould KL, Lipscomb K: Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol. 974;34:48-55.","DOI":"10.1016\/0002-9149(74)90092-7"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib20","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/01.RES.43.2.242","article-title":"Pressure-flow characteristics of coronary stenoses in intact unsedated dogs at rest and during coronary vasodilation","volume":"43","author":"Gould","year":"1978","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0735-1097(86)80266-2","article-title":"Assessment of coronary stenoses by myocardial imaging during coronary vasodilation. VII. Validation of coronary flow reserve as a single integrated measure of stenosis severity accounting for all its geometric dimensions","volume":"7","author":"Kirkeeide","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0002-9149(74)90127-1","article-title":"A method for assessing stress induced regional malperfusion during coronary arteriography: experimental validation and clinical application","volume":"34","author":"Gould","year":"1974","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0002-9149(78)90165-0","article-title":"Noninvasive assessment of coronary stenoses by myocardial imaging during coronary vasodilation. I. Physiologic principles and experimental validation","volume":"41","author":"Gould","year":"1978","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0002-9149(78)90166-2","article-title":"Noninvasive assessment of coronary stenoses by myocardial imaging during coronary vasodilation. II. Clinical methodology and feasibility","volume":"41","author":"Gould","year":"1978","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib25","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0002-9149(78)90095-4","article-title":"Assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilatation. IV. Limits of stenosis detection by idealized, experimental, cross-sectional myocardial imaging","volume":"42","author":"Gould","year":"1978","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib26","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0002-9149(79)80005-3","article-title":"Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. V. Detection of 47% diameter coronary stenosis with intravenous 13NH4+ and Emission Cemputed Tcmographytin Intact Dogi","volume":"43","author":"Gould","year":"1979","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib27","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0735-1097(86)80336-9","article-title":"Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilation. VIII. Feasibility of 3D cardiac positron imaging without a cyclotron using generator produced Rb-82","volume":"7","author":"Gould","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib28","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/01.CIR.87.4.1354","article-title":"Experimental basis of determining maximal coronary myocardial and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after PTCA","volume":"86","author":"Pijls","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib29","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1161\/01.CIR.89.4.1530","article-title":"Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease","volume":"89","author":"Gould","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib30","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1001\/jama.1995.03530110056036","article-title":"Changes in myocardial perfusion abnormalities by positron emission tomography after long term, intense risk factor modification","volume":"274","author":"Gould","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib31","unstructured":"Gould K, Schelbert H, Narula J. Chapter 19, positron emission tomography in heart disease. In: Hurst's the heart 2017. McGraw Hill, New York; p. 893\u2013921."},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib32","series-title":"Chapter 6: clinical coronary physiology and quantitative myocardial perfusion, atlas of nuclear cardiology","first-page":"161","author":"Gould","year":"2021"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ahj.2021.03.012","article-title":"Design and rationale of the randomized trial of comprehensive lifestyle modification, optimal pharmacological treatment and utilizing PET imaging for quantifying and managing stable coronary artery disease (the CENTURY study)","volume":"237","author":"Kitkungvan","year":"2021","journal-title":"Am Heart J"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib34","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1093\/eurheartj\/ehaf356","article-title":"Optimal medical care and coronary flow capacity-guided myocardial revascularization vs usual care for chronic coronary artery disease: the CENTURY trial","volume":"46","author":"Gould","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib35","first-page":"565","article-title":"Routine clinical quantitative rest stress myocardial perfusion for managing coronary artery disease: clinical relevance of test-retest variability","volume":"10","author":"Kitkungvan","year":"2017","journal-title":"J Am Coll Cardiology CV Imaging"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/eurheartj\/ehaf1046","article-title":"The year in cardiovascular medicine 2025: the top 10 papers in interventional cardiology","volume":"47","author":"Barbato","year":"2026","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2026.120831_bib37","first-page":"707","article-title":"Economic analysis of clinical positron emission tomography of the heart with Rubidium-82","volume":"30","author":"Gould","year":"1989","journal-title":"J Nucl Med"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026001978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026001978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:58:07Z","timestamp":1790107087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915026001978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":37,"alternative-id":["S0021915026001978"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120831","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative PET coronary flow capacity and comprehensive management of chronic CAD: Lessons from the randomized CENTURY trial","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120831","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120831"}}